Astec Lifesciences Ltd Q3 FY23 Share Price & Earnings Call Analysis

Financials of Astec Lifesciences Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Astec Lifesciences Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +126.97142.85110.7950.79153.7569.3798.5593.86119.5391.0873.72124.72158.62
Expenses +121.56139.72114.2269.13141.05115.62118.2999.60114.00102.0780.41120.74149.46
Operating Profit5.413.13-3.43-18.3412.70-46.25-19.74-5.745.53-10.99-6.693.989.16
OPM %4.26%2.19%-3.10%-36.11%8.26%-66.67%-20.03%-6.12%4.63%-12.07%-9.07%3.19%5.77%
Other Income +2.571.710.980.912.050.922.001.910.790.511.12-1.272.63
Interest6.406.465.996.096.677.049.339.9210.4011.048.407.177.92
Depreciation7.769.399.168.709.019.2711.4711.4011.5811.4910.4411.2211.77
Profit before tax-6.18-11.01-17.60-32.22-0.93-61.64-38.54-25.15-15.66-33.01-24.41-15.68-7.90
Tax %-19.58%-25.61%-23.75%-24.49%4.30%-35.56%0.03%60.52%2.62%0.03%0.04%0.06%-1.90%
Net Profit +-4.97-8.18-13.42-24.32-0.96-39.71-38.55-40.37-16.08-33.03-24.42-15.69-7.75
EPS in Rs-2.22-3.66-6.00-10.86-0.43-17.73-17.21-18.03-7.18-14.75-10.96-7.05-3.48

Financials of Astec Lifesciences Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +267233299368431523555677628458381448
Expenses +213201236299354437443522551464448453
Operating Profit54326369768511215477-6-66-5
OPM %20%14%21%19%18%16%20%23%12%-1%-17%-1%
Other Income +-164-812111281013663
Interest1313121112135921253735
Depreciation131014151923263434364445
Profit before tax1312295656618912135-62-141-81
Tax %-17%59%33%37%36%23%27%26%27%-24%-4%-0%
Net Profit +15519353648659026-47-135-81
EPS in Rs6.662.248.5715.6516.0321.2129.0440.1211.41-20.95-60.16-36.32
Dividend Payout %16%0%15%8%8%6%5%3%12%0%0%0%

Financials of Astec Lifesciences Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital191920202020202020202022
Reserves11699119150183227290377400350215368
Borrowings +9312712712517699187279341494555449
Other Liabilities +13385691198322618122121911292103
Total Liabilities362330334413461572678897979975881942
Fixed Assets +13395103115167194213340318386499478
CWIP1220842192411623127165210
Investments000000000000
Other Assets +216215223256275354349534534424361463
Total Assets362330334413461572678897979975881942

Financials of Astec Lifesciences Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +7-13196515168-8247510-8-81
Cash from Investing Activity +-19-17-18-49-52-74-73-104-113-135-15-4
Cash from Financing Activity +1231-1-1837-958180381252494
Net Cash Flow-021-3-0000-0009
Free Cash Flow-13-39-115-37123-111-80-42-125-24-86
CFO/OP19%-24%41%116%41%219%13%34%104%-211%20%1,768%

Financials of Astec Lifesciences Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days14212613512210311212314890135141202
Inventory Days147177133122121131113176268224196169
Days Payable17916911615583218137179161102100107
Cash Conversion Cycle1091341528914225100145197256237263
Working Capital Days19-281-8-28412-17-1-26-56
ROCE %20%12%20%22%20%20%22%22%8%-4%-13%-5%